Seed
Clear all
Showing 8 companies
Biotechnology
DeepTech
Health
11 - 50 employees
Seed

3Helix is a biotechnology research center. They provide pathology, biomechanics, cell biology, and regenerative medicine services. An online inquiry form is available on the company's website.

Biotechnology
DeepTech
51 - 200 employees
Seed

BioSkryb Genomics is a pioneering company in single-cell analysis, offering patented technologies like Primary Template-directed Amplification (PTA) and the Base Jumper™ bioinformatics platform. Their products, including Resolve OME™ and Resolve DNA®, enable comprehensive genomic and transcriptomic analysis from individual cells, addressing the critical need for precision in understanding cellular heterogeneity and disease mechanisms. With a strong focus on cancer research and a commitment to advancing treatment development, BioSkryb is positioned as a leader in the rapidly evolving field of single-cell genomics, supported by strategic partnerships and a robust intellectual property portfolio.

Biotechnology
DeepTech
Health
51 - 200 employees
Seed

DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.

Biotechnology
DeepTech
Health
Manufacturing
11 - 50 employees
Seed

Emmaus Medical is a Torrance, California private pharmaceutical company developing and bringing to market new treatments for rare diseases and conditions. Emmaus Medical launched its first product, NutreStore [L-glutamine powder for an oral solution] for the treatment of Short Bowel Syndrome (SBS) in June 2008. The company is currently conducting a Phase 3 clinical trial to investigate the safety and efficacy of oral L-glutamine for the treatment of sickle cell disease. They are initially focusing our product development efforts on Sickle Cell Disease, a genetic disorder Emmaus Medical has received FDA orphan drug designation and fast track designation for its sickle cell treatment. The company was founded in 2000 and is headquartered in Torrance, California, United States.

Hardware
Internet Services
Sales and Marketing
Software
51 - 200 employees
Seed

Kixie is the sales engagement platform that boosts sales team performance with ultra-reliable, easily-automated calling and texting for Hubspot, Salesforce, Pipedrive and other leading CRMs. Kixie connects agents to prospects naturally and automatically, reveals valuable insights about conversations and provides truly dependable service. The Kixie platform includes the PowerCall dialer & mobile apps, Automations, Analytics and Contact Center. With Kixie, sales teams have the power to achieve their most ambitious goals. It's better sales, made simple. Try it free at kixie.com.

Biotechnology
DeepTech
Health
11 - 50 employees
Seed

Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.

Biotechnology
DeepTech
Health
201 - 1000 employees
Seed

Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics’ products in development and Singular Genomics’ core product tenets: accuracy, speed, flexibility and scale. Singular Genomics’ first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution.

Biotechnology
Data and Analytics
DeepTech
11 - 50 employees
Seed

Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to capture images and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.